logo-loader
THC Global Group Ltd

THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.
 
"It's a significnat milestone ... we now are a farm-to-pharma process which means that we grow, and we actually then process to a complete medicine," says Charteris. 
 
He continues, "This is a great position for us to be in and we're the only company presently that holds the whole suite and also have their own breeds and processing. 
 
"The bigger news for us is that we're a global company - this now allows us to produce and formulate our own brands with our own products."

Quick facts: THC Global Group Ltd

Price: 0.415 AUD

Market: ASX
Market Cap: $56.72 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: THC Global receives final licences and will complete product...

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive on receiving the final licences required for Australian production and distribution of narcotic medicines, including medicinal cannabis, for the recently opened Southport and Bundaberg manufacturing facilities...

1 week, 6 days ago

2 min read